Adherium to present at eyeforpharma Barcelona 2016

Adherium to present at eyeforpharma Barcelona 2016

14 Mar 2016

Melbourne, Australia, 15 March 2016: Adherium Limited (ASX: ADR), a global leader in digital health technologies which address sub-optimal medication use in chronic disease, will this week be presenting at two industry conferences, in Europe and Australia.

CEO Garth Sutherland will be presenting at eyeforpharma Barcelona 2016, the pharma-stakeholder summit taking place between 15-17 March.

The presentation, A Brave New World: The Digitisation of Medicine & its Impact on Patient Outcomes, will focus on the transformation of the lives of patients with chronic respiratory disease through digital technology. It will draw on Adherium’s independent clinical data, demonstrating the link between digital adherence and patient outcomes and will outline the impact of digital technology application on the clinical and commercial performance of drugs.

eyeforpharma is an annual global event for senior pharmaceutical executives that focuses on customer and patient empowerment. About 1,000 delegates are expected, mostly vice president and director level.

The presentation will take place at 16.15 CET, 16 March, at the Centre Convencions Internactional Barcelona.

Bronwyn Le Grice, Head of Commercial Development & Corporate Affairs, will also be presenting at BioMelbourne Network’s Medical Device and Diagnostics Lab for healthcare company executives and industry professionals, taking place in Melbourne on 17 March 2016.

The presentation, Transforming Patient Health through Digital Technologies is part of the Connected & Data-Driven Healthcare session, taking place at 11.30am AEDT, at the Spring Street Conference Centre, Melbourne.